Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05992129
Other study ID # CTUM212170
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 1, 2022
Est. completion date May 19, 2023

Study information

Verified date August 2023
Source Universidad del Magdalena
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to assess whether high or low arch foot types influence the overall performance of the athlete.


Description:

After meeting the eligibility criteria for the study, university athletes have their general athletic condition variables evaluated in the laboratory and in the field. Subsequently, athletes with high and low arches perform 12-week foot muscle strengthening exercises to re-evaluate the variables in both athletes with high and low arch types who performed the strengthening exercises, as well as those with neutral arch who did not perform the exercises.


Recruitment information / eligibility

Status Completed
Enrollment 97
Est. completion date May 19, 2023
Est. primary completion date December 21, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 26 Years
Eligibility Inclusion Criteria: - University athletes with 4 years of continuous training - high foot - low foot. - Neutral foot Exclusion Criteria: - Any pain - active injuries - biomechanical alteration in their lower extremities. - Spine disorders - Spine surgery - abdominal surgery, - neural or vestibular disease - arthritis of the lower extremities - used of alcohol, sedatives, pain relievers, cold medication, or stimulants in the last year - rigid pronated foot

Study Design


Related Conditions & MeSH terms


Intervention

Other:
foot exercise
These are foot and ankle muscle strengthening exercises described and evaluated by the literature

Locations

Country Name City State
Colombia Universidad del Magdalena Santa Marta Magdalena

Sponsors (1)

Lead Sponsor Collaborator
Universidad del Magdalena

Country where clinical trial is conducted

Colombia, 

References & Publications (4)

Bobbert MF, Gerritsen KG, Litjens MC, Van Soest AJ. Why is countermovement jump height greater than squat jump height? Med Sci Sports Exerc. 1996 Nov;28(11):1402-12. doi: 10.1097/00005768-199611000-00009. — View Citation

Garcia-Vaquero MP, Moreside JM, Brontons-Gil E, Peco-Gonzalez N, Vera-Garcia FJ. Trunk muscle activation during stabilization exercises with single and double leg support. J Electromyogr Kinesiol. 2012 Jun;22(3):398-406. doi: 10.1016/j.jelekin.2012.02.017. Epub 2012 Mar 20. — View Citation

Marcos MA, Koulla PM, Anthos ZI. Preseason Maximal Aerobic Power in Professional Soccer Players Among Different Divisions. J Strength Cond Res. 2018 Feb;32(2):356-363. doi: 10.1519/JSC.0000000000001810. — View Citation

Oliva-Lozano JM, Muyor JM. Core Muscle Activity During Physical Fitness Exercises: A Systematic Review. Int J Environ Res Public Health. 2020 Jun 16;17(12):4306. doi: 10.3390/ijerph17124306. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Alterations change from baseline of the muscles of the center of gravity at 12 weeks Measurement of the activity of the muscles of the center of gravity with electromyography
Voltage amplitude of the anterior rectus muscle measured in millivolts
Erector spinae muscle voltage amplitude measured in millivolts
Voltage amplitude of the external oblique muscle measured in millivolts
Voltage amplitude of the Internal oblique muscle measured in millivolts
Electrodes were placed on the subjects according to literature recommendations (Oliva-Lozano & Muyor, 2020). Three sets of three exercise repetitions were performed (García-Vaquero et al., 2012).
Baseline and week 12
Primary Alterations change from baseline of static stability: total mean distance, Anterioposterior distance and mediolateral distance at 12 weeks The static stability in terms of total mean distance, Anterioposterior distance and mediolateral distance were measured in millimeters.
The stability was measured when the athlete stood on the dominant leg trying to maintain balance for 10 seconds.
Baseline and week 12
Primary Alterations change from baseline of static stability: total mean speed, anterio-posterior speed and mediolateral speed at 12 weeks The static stability in terms of static stability: total mean speed, anterio-posterior speed and mediolateral speed were measured in millimeters/seconds The stability was measured when the athlete stood on the dominant leg trying to maintain balance for 10 seconds. Baseline and week 12
Primary Alterations change from baseline of static stability: covered area at 12 weeks The static stability in terms of static covered area was measured in millimeters² The stability was measured when the athlete stood on the dominant leg trying to maintain balance for 10 seconds. Baseline and week 12
Primary Alterations change from baseline of dynamic stability: mean power at 12 weeks The dynamic stability in terms of mean power was measured in watts/kilogram
The participants were instructed to perform five single-leg jumps using their dominant foot.
Baseline and week 12
Primary Alterations change from baseline of dynamic stability: left-right and forward/backward displacement at 12 weeks The dynamic stability in terms of left-right and forward/backward displacement were measured in centimeters The participants were instructed to perform five single-leg jumps using their dominant foot. Baseline and week 12
Primary Alterations change from baseline of dynamic stability: covered area at 12 weeks The dynamic stability in terms of covered area measured in centimeters² The participants were instructed to perform five single-leg jumps using their dominant foot. Baseline and week 12
Primary Alterations change from baseline in sport performance of maximum oxygen consumption (VO2max) and anaerobic threshold (AT) at 12 weeks We used an Ergospirometry system to assess:
VO2max and AT measured in milliliters/kilogram/minute
They followed Marcos' protocol for a continuous treadmill exercise test (Marcos et al., 2018) and estimated VO2max and AT.
Baseline and week 12
Primary Alterations change from baseline in sport performance of countermovement jump test: maximum force measured at 12 weeks Sport performance of countermovement jump test: maximum force measured in Newton/kilogram.
For the countermovement jump (CMJ), participants started upright, knees and hips flexed, and then jumped while crossing their hands behind their back (Bobbert et al., 1996).
Baseline and week 12
Primary Alterations change from baseline in sport performance of countermovement jump test: rate of force development at 12 weeks Sport performance of countermovement jump test: rate of force development measured in Newton/kilogram/second.
For the countermovement jump (CMJ), participants started upright, knees and hips flexed, and then jumped while crossing their hands behind their back (Bobbert et al., 1996).
Baseline and week 12
Primary Alterations change from baseline in sport performance of countermovement jump test: maximum power at 12 weeks Sport performance of countermovement jump test: maximum power measured in Watts/kilogram.
For the countermovement jump (CMJ), participants started upright, knees and hips flexed, and then jumped while crossing their hands behind their back (Bobbert et al., 1996).
Baseline and week 12
Primary Alterations change from baseline in sport performance of countermovement jump test:maximum velocity at 12 weeks Sport performance of countermovement jump test: maximum velocity measured in meters/second.
For the countermovement jump (CMJ), participants started upright, knees and hips flexed, and then jumped while crossing their hands behind their back (Bobbert et al., 1996).
Baseline and week 12
Primary Alterations change from baseline in sport performance of record time 40-meter sprint test at 12 weeks Sport performance of of 40-meter sprint test: record time measured in seconds. To measure the 40-meter sprint, photocell sensors and biomechanical equipment were used and participants ran at their maximum speed over a distance of 40 meters Baseline and week 12
Primary Alterations change from baseline in sport performance of speed 40-meter sprint test at 12 weeks Sport performance of of 40-meter sprint test: speed measured in meters/second. To measure the 40-meter sprint, photocell sensors and biomechanical equipment were used and participants ran at their maximum speed over a distance of 40 meters Baseline and week 12
Primary Alterations change from baseline in sport performance of acceleration 40-meter sprint test at 12 weeks Sport performance of of 40-meter sprint test: acceleration measured in meters/second².
To measure the 40-meter sprint, photocell sensors and biomechanical equipment were used and participants ran at their maximum speed over a distance of 40 meters
Baseline and week 12
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1